Lv3
390 积分 2021-10-19 加入
SGLT2 inhibitors ameliorate NAFLD in mice via downregulating PFKFB3, suppressing glycolysis and modulating macrophage polarization
1个月前
已完结
Effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes in people with diabetes and advanced chronic kidney disease
1个月前
已完结
Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Dialysis and Cardiovascular Disease in Patients With Stage 5 Chronic Kidney Disease
1个月前
已完结
DPP-4i versus SGLT2i as modulators of PHD3/HIF-2α pathway in the diabetic kidney
1个月前
已完结
Empagliflozin in Patients with Chronic Kidney Disease
1个月前
已完结
Metabolic pathways and immunometabolism in rare kidney diseases
2个月前
已完结
Biomarker prediction for membranous nephropathy prognosis by microarray analysis
2个月前
已完结
Biomarker Identification in Membranous Nephropathy Using a Long Non-coding RNA-Mediated Competitive Endogenous RNA Network
2个月前
已完结
Identification of Hub Genes and Immune-Related Pathways for Membranous Nephropathy by Bioinformatics Analysis
2个月前
已完结
皖公网安备34019202002308
